Phase 3 Kawasaki Disease Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Kawasaki DiseaseCoronary Artery Abnormalities
Children's Hospital of Fudan University9 enrolled1 locationNCT07530640
Recruiting
Phase 3
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Kawasaki Disease
Assistance Publique - Hôpitaux de Paris84 enrolled1 locationNCT04656184